The present invention relates to a method of treatment of hot flushes with a 5-HT2C receptor agonist and in particular to the use of the selective 5-HT2C receptor agonists 1-[6-chloro-5-(trifluoromethyl)-2-pyridinyl]-piperazine and (S)-(+)-3-[(2,3-dihydro-5-methoxy-1H-inden-4-yl)oxy-pyrrolidine or pharmaceutically acceptable acid addition salts thereof for the manufacture of a pharmaceutical formulation adapted for the treatment of hot flushes.

 
Web www.patentalert.com

< Rapidly absorbed liquid compositions

< Stimulation methodologies and apparatus for control of brain states

> Compositions comprising sibutramine metabolites in combination with phosphodiesterase inhibitors

> Heteroaryl-fused nitrogen heterocycles as therapeutic agents

~ 00232